Vaccine Development Against Lymphocystis Disease Virus in Fish
Author Information
Author(s): Zheng Fengrong, Sun Xiuqin, Wu Xing'an, Liu Hongzhan, Li Jiye, Wu Suqi, Zhang Jinxing
Primary Institution: First Institute of Oceanography, State Oceanography Administration of China
Hypothesis
Can a genetically engineered vaccine effectively protect Japanese flounder against lymphocystis disease virus (LCDV)?
Conclusion
The study found that the recombinant plasmid vaccine significantly induced immune responses and provided protection against LCDV in Japanese flounder.
Supporting Evidence
- The vaccine induced unique immune responses depending on the injection route.
- Higher doses of the vaccine resulted in significantly increased immune responses.
- Fish vaccinated with the plasmid showed lower tumor growth rates after exposure to LCDV.
Takeaway
Scientists created a vaccine to help fish fight a virus that makes them sick, and it worked really well!
Methodology
The vaccine was tested on Japanese flounder using different doses and injection methods, and immune responses were measured.
Limitations
The study did not evaluate the effects of different doses of DNA for intramuscular injection in detail.
Participant Demographics
Japanese flounder, approximately 15–20 cm in length and 60–80 g in weight.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website